Please login to the form below

Not currently logged in

Actelion reports late-stage trial failure as J&J talks continue

Actelion HQ Switzerland

MAESTRO trial results disappointing but unlikely to lead to a breakdown in talks

Life sciences to play key role in UK’s post-Brexit strategy

UK flagPrime minister unveils plans to boost jobs, growth and commercialise country’s science base

Sobi looks to real-world trial to push Elocta take-up

Swedish Orphan Biovitrum (Sobi)Aims to show haemophilia A treatment’s benefit to reimbursement authorities

AZ tweaks immuno-oncology trials as it chases lung cancer leaders

AstraZeneca AZToughens targets for durvalumab in NSCLC monotherapy and combination study

Allergan plans to file oral uterine fibroid drug in US by year-end

Allergan logoAnalysts predict treatment will reach blockbuster sales as phase III trials meet objectives

Merck forges cancer-focused big data alliance with Palantir

Merck KGaAPlans to develop a collaborative analytics platform to accelerate research and improve outcomes

Biogen proffers new data to support high-priced Spinraza

Biogen Idec buildingTrial demonstrates statistically-significant risk reduction in paediatric SMA for potential blockbuster drug

J&J partner drive nets 15 new deals, and another NASH drug

Fosters new collaborations in treatment-resistant depression, infectious diseases and cancer

Sanofi and Merck & Co finalise vaccine alliance split

Dissolve Sanofi Pasteur MSD after poor sales growth

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

Featured jobs

Subscribe to our email news alerts


Add my company

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Medius Deal Watch
Deal Watch December 2016
Allergan, AZ, BMS, Pfizer, Roche and more feature in this month's pharma deals round-up...
The Young Dementia Network - much more than a logo
Welcome to the second and final part of my two-part blog....
Patient-centred care innovation in dementia: a conversation with Neil Maiden
Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...